average selling price increased by 14.6%. Cost of sales in the third quarter of 2017 accounted for 77.4% of revenue, down from the same period of 2016, which accounted for 87.3% of revenue because the
18.85 million mainly from the decrease of an unrealized gain from mark-to-market price of investment in listed equity securities and the gain on debt securities from the reduction the Company’s investment
of a Community Mall for sale 2. Total expenses amounted to 110.45 million baht, a decrease of 1,260.79 million baht or 91.94 percent from the previous year to consist of 2.1. Cost of sales - property
exported. Cost of Sales for Q2 / 2022 and Q2 / 2021 was 469.79 million baht and 453.66 million baht, respectively. It increased 16.13 million baht or 3.56% when compared with Q2 / 2021. The increase in cost
Cost 0.21 0.20 0.23 0.25 -0.02 -8.70 Profit (loss) before income tax expenses -13.36 -12.57 -15.88 -17.54 2.52 -15.87 Income tax (expense) revenue -1.52 -1.43 0.46 0.51 -1.98 -430.43 Net profit (loss
August 30th, 2019 passed the following resolution concerning the acquisition of Nan-Ram Hospital Company Limited’s ordinary share in the amount of 16,000,000 shares at price of baht 10 par share, totally
) Acquired property: Ordinary shares in VHA of 46,800 shares, equivalent to 30 percent of paid-up capital Acquisition price: 46,800 Hong Kong Dollars (or equivalent to Baht 193,302.72) which is a par-value
August 30th, 2019 passed the following resolution concerning the acquisition of Nan-Ram Hospital Company Limited’s ordinary share in the amount of 16,000,000 shares at price of baht 10 par share, totally
Sales and Expenses Major costs of the Company compose of cost of sales, selling expense, administrative expense and interest expense. In the first nine months of 2016 and 2017, the Company shows its cost
Expense (146.81) (13.35%) (140.83) (9.09%) 5.98 4.25% Other Expenses (25.98) (2.36%) (17.80) (1.15%) 8.18 45.96% 0.00 - 0.00 - - - EBIT 105.71 9.61% 358.66 23.16% (252.95) (70.53%) Financing cost (56.33